Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Accured Expenses (2016 - 2025)

Veracyte's Change in Accured Expenses history spans 14 years, with the latest figure at -$718000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 104.56% year-over-year to -$718000.0; the TTM value through Dec 2025 reached $6.3 million, up 78.37%, while the annual FY2025 figure was $6.3 million, 78.37% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$718000.0 at Veracyte, down from $9.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $12.9 million in Q2 2024 and bottomed at -$9.0 million in Q1 2024.
  • The 5-year median for Change in Accured Expenses is $129000.0 (2021), against an average of $984300.0.
  • The largest annual shift saw Change in Accured Expenses crashed 1879.74% in 2023 before it skyrocketed 45525.0% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $11.1 million in 2021, then plummeted by 81.02% to $2.1 million in 2022, then grew by 29.34% to $2.7 million in 2023, then crashed by 112.89% to -$351000.0 in 2024, then plummeted by 104.56% to -$718000.0 in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Change in Accured Expenses are -$718000.0 (Q4 2025), $9.1 million (Q3 2025), and $6.8 million (Q2 2025).